(294 days)
Not Found
No
The description details a software-controlled peristaltic pump with safety features and flow rate control based on programmed intervals, but it does not mention any AI or ML algorithms for decision-making, pattern recognition, or adaptive learning.
No.
This device is an enteral feeding pump that delivers nutrition solutions; it is not described as treating, preventing, or diagnosing a disease or condition, which are characteristics of a therapeutic device.
No.
The device is described as an "Enteral Feeding Pump designed to deliver programmed doses of enteral nutrition solutions," which is a therapeutic function, not a diagnostic one. It dispenses rather than analyzes or detects conditions.
No
The device description clearly outlines hardware components such as a rotary peristaltic pump, motor, microcontroller, air-in-line sensor, pressure sensors, batteries, and a charger. While it is software-controlled, it is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "deliver programmed doses of enteral nutrition solutions at selectable rates." This describes a device that administers substances to a patient, not a device that performs tests on samples taken from the body to diagnose or monitor a condition.
- Device Description: The description focuses on the mechanical and electrical aspects of a pump designed for delivering liquids. It mentions features like peristaltic action, flow rate control, battery operation, and safety features related to fluid delivery (air-in-line, pressure sensors). None of these relate to in vitro testing.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting analytes, or providing diagnostic information based on laboratory tests.
In summary, the EnteraLite® Infinity® Enteral Feeding Pump is a medical device used for administering nutrition, not for performing in vitro diagnostic tests.
N/A
Intended Use / Indications for Use
The EnteraLite® Infinity® Enteral Feeding Pump is a rotary peristaltic pump designed to deliver programmed doses of enteral nutrition solutions at selectable rates.
Product codes (comma separated list FDA assigned to the subject device)
LZH
Device Description
The EnteraLite® Infinity® Enteral Feeding Pump as referred to as Infinity® with disposable set is a small, lightweight pump used to dispense liquid nutrients at a user controlled rate to patients. The device may be used in the hospital or at home by bedridden or ambulatory patients. The device is also designed for use with pediatric patients.
The device is software controlled, variable flow rate, peristaltic pump. It operates up to 24 hours (at a nominal flow rate of 125 ml/hr) from internal rechargeable batteries. The batteries are recharged by a wall mounted charger that plugs into a standard 100 to 240 volt alternating current wall socket. The charger is available in various input voltage and plug configurations to accommodate international requirements. The charger converts line voltage to a safe low voltage of 5 volts DC that is supplied from the charger to the pump. A "fuel gauge" type indicator on the pump's LCD display continuously shows the state of battery charge.
The pump motor runs at a single speed and is turned on and off at programmed intervals to obtain the desired flow rate. The motor drive circuit is controlled by a microcontroller that allows the motor to pause longer at lower flow rates with correspondingly shorter pauses at higher flow rates. The software embodied within the microcontroller is validated and verified as part of the design process.
The pump includes several safety features. An air-in-line sensor rapidly detects whenever nutrient flow is interrupted and alerts the user with both a visual and audible alarm. Two pressure sensors detect occlusions both on the nutrient bag (distal) side and the patient (proximal) side of the pump. The user is alerted to proximal or distal occlusions by both visual and audible alarms.
The disposable tubing set consists of a bag, or spike for nutrient bag, PVC connecting tubing, an integral cassette with a silicone pumping segment, and an enteral adapter. The set also contains a patented anti-free flow device within the cassette, which prevents free flow of fluids if the tubing set is inadvertently or purposely removed from the pump.
A backpack (convertible to a waistpack) is available for use under ambulatory conditions. The pump may be operated in any orientation.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
pediatric patients
Intended User / Care Setting
hospital or at home by bedridden or ambulatory patients
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Performance Data:
The following verification test reports were performed to verify contact of the door/ top housing to the cassette when installed. Based on the results of this testing including statistical and graphical analysis, the addition of bumps to the cassette passes the acceptance criteria.
| Characteristic | Test report | Result summary |
|---|---|---|
| Design verification | TR-49430 | Pass |
| Design verification | TR-49071 | Pass |
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K031199- EnteraLite Infinity Enteral Feeding Pump- ZEVEX, INC
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the word "MOOG" in white text on a black background. The font is sans-serif and appears to be slightly distressed or textured, giving it a rough or vintage look. The letters are evenly spaced and easily readable.
Roog Medical Devices G
KISH154
510(k) Summary
FEB 1 2 2014
This summary of the "Special 510(k): Device modification" information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 CFR 807.92.
| Date prepared: | 11/21/2013 |
|---|---|
| Owner's name & address: | ZEVEX, Inc. |
| 4314 Zevex Park Lane | |
| Salt Lake City, UT 84123 | |
| Phone number: | 801-264-1001 x291 |
| Fax number: | 801-264-1051 |
| Contact person: | Niloufar (Nellie) Samimi |
| Trade name: | EnteraLite® Infinity® Enteral Feeding Pump |
| Common name: | Disposable Tubing sets |
| Classification name: | 21 CFR 880.5725 Infusion pump |
Substantial equivalence claimed to:
K031199- EnteraLite Infinity Enteral Feeding Pump- ZEVEX, INC
Description:
The EnteraLite® Infinity® Enteral Feeding Pump as referred to as Infinity® with disposable set is a small, lightweight pump used to dispense liquid nutrients at a user controlled rate to patients. The device may be used in the hospital or at home by bedridden or ambulatory patients. The device is also designed for use with pediatric patients.
The device is software controlled, variable flow rate, peristaltic pump. It operates up to 24 hours (at a nominal flow rate of 125 ml/hr) from internal rechargeable batteries. The batteries are recharged by a wall mounted charger that plugs into a standard 100 to 240 volt alternating current wall socket. The charger is available in various input voltage and plug configurations to accommodate international requirements. The charger converts line voltage to a safe low voltage of 5 volts DC that is supplied from the charger to the pump. A "fuel gauge" type indicator on the pump's LCD display continuously shows the state of battery charge.
The pump motor runs at a single speed and is turned on and off at programmed intervals to obtain the desired flow rate. The motor drive circuit is controlled by a microcontroller that allows the motor to pause longer at lower flow rates with correspondingly shorter
Salt Lake City, Utah 84 nh 801 264 100
4314 Zevex Park Lan
1x 801.264.105 800.970.2337
| CURLIN
| INFUSION |
|---|
| ZEVEX |
| ENTERAL |
1
Image /page/1/Picture/0 description: The image shows the word "MOOG" in white letters against a black background. The letters are outlined in white, giving them a slightly blurred appearance. The font is simple and sans-serif, with each letter being clearly distinguishable. The overall impression is clean and minimalist.
pauses at higher flow rates. The software embodied within the microcontroller is validated and verified as part of the design process.
The pump includes several safety features. An air-in-line sensor rapidly detects whenever nutrient flow is interrupted and alerts the user with both a visual and audible alarm. Two pressure sensors detect occlusions both on the nutrient bag (distal) side and the patient (proximal) side of the pump. The user is alerted to proximal or distal occlusions by both visual and audible alarms.
The disposable tubing set consists of a bag, or spike for nutrient bag, PVC connecting tubing, an integral cassette with a silicone pumping segment, and an enteral adapter. The set also contains a patented anti-free flow device within the cassette, which prevents free flow of fluids if the tubing set is inadvertently or purposely removed from the pump.
A backpack (convertible to a waistpack) is available for use under ambulatory conditions. The pump may be operated in any orientation.
Intended use:
The EnteraLite® Infinity® Enteral Feeding Pump is a rotary peristaltic pump designed to deliver programmed doses of enteral nutrition solutions at selectable rates.
Summary of technological characteristics:
The modified device and the predicate device, have the exact same design features with one exception. The proposed device's cassette component has 3 bumps added creating a greater interference between the cassette and the pump door.
Risk Analysis:
The risk analysis methods used to assess the safety and effectiveness impact of the modification was Failure Modes, Effects and Criticality Analysis (FMECA). The Design Requirements document and Design Verification document was also reviewed.
It was determined that the addition of the bumps to the cassette did not add any new safety risk to the disposable tubing set.
It was determined that he previously conducted design verification activities were still applicable. The proposed design modification will not affect the following:
-
- Operation and performance of the cassette.
-
- Shelf Life
-
- Biocompatibility
-
- Packaging and transportation
2
Image /page/2/Picture/0 description: The image contains the word "MOOG" in white font on a black background. The font is simple and sans-serif. The letters are evenly spaced and of similar size. The image is clear and easy to read.
Non-Clinical Performance Data:
The following verification test reports were performed to verify contact of the door/ top housing to the cassette when installed. Based on the results of this testing including statistical and graphical analysis, the addition of bumps to the cassette passes the acceptance criteria.
| Characteristic | Test report | Result summary |
|---|---|---|
| Design verification | TR-49430 | Pass |
| Design verification | TR-49071 | Pass |
Conclusion:
The proposed disposable tubing set is substantially equivalent to the predicate device, disposable tubing set.
The devices have the SAME:
- l. Intended use
-
- Operating Principle
-
- Materials
-
- Construction
-
- Shelf life
-
- Packaging
3
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. The eagle is black, and the text is also black.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 12, 2014
ZEVEX, Incorporated Mr. Niloufar Sammi Regulatory Affairs Specialist III 4314 Zevex Park Lane Salt Lake City, Utah 84123
Re: K131154
Trade/Device Name: EnteraLite® Infinity® Enteral Feeding Pump Regulation Number: 21 CFR 880.5725 Regulation Name: Infusion Pump Regulatory Class: II Product Code: LZH Dated: February 5, 2014 Received: February 5, 2014
Dear Mr. Sammi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Image /page/4/Picture/6 description: The image shows the name Kwame Ulmer in a stylized font. The name Kwame is on the top line, and Ulmer is on the bottom line. To the right of the name is a logo that appears to be a stylized letter 'A'.
for
Erin I. Keith, M.S. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K131154
Device Name
EnteraLite Infinity Enteral Feeding Pump
Indications for Use (Describe)
The EnteraLite Infinity Enteral Feeding Pump is a rotary peristaltic pump designed to deliver programmed doses of enteral nutrition solutions at selectable rates.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
[ ] Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FOR FOR FORMEY - FORT CONTRACT CONTRACTOR CONTRACTOR
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Image /page/5/Picture/13 description: The image shows the logo for the Food and Drug Administration (FDA). The logo is in black and white and features the letters "FDA" in a stylized font. The letters are bold and have a double-lined border. The logo is simple and recognizable.
Digitally signed by Richard C. Chapman Date: 2014.02.10 16:01:24 -05'00'
Form Approved: OMB No. 0910-0120 Expiration Date: December 31, 2013 See PRA Statement on last page.
6
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."